Human peripheral blood lymphocytes (PBL) of non-immune donors produced interferon (IFN) when cultured with dengue virus-infected cells. IFN was detected as early as 2 h after exposure of PBL to dengue virus-infected cells, and the titres reached a maximum by 16 h of incubation. Dengue virus-infected cells treated with glutaraldehyde, which produced no infectious dengue virus, also induced IFN. These results indicate that PBL produce IFN in response to dengue virus-infected cells and that the production of IFN by PBL is due to stimulation of PBL by dengue virusinfected cells. Characterization of IFN-producing PBL with monoclonal antibodies demonstrated that the predominant producing cells were contained in M 1 ÷ and T3-subsets, and that the Leul 1 + subset contains some IFN-producing cells. The IFNs that were produced by the PBL exposed to dengue virus-infected cells were analysed by radioimmunoassay employing monoclonal antibodies specifically to detect IFN-~ or IFN-1,. IFN-7 as well as IFN-~ was produced by PBL exposed to dengue virus-infected cells. Both IFN-~ and IFN-7 were predominantly produced by PBL contained in M 1 ÷ and T3-subsets. The observation that PBL of non-immune donors produced IFN-7 as well as IFN-~ in response to dengue virus-infected cells is of interest in view of the immunoregulatory roles of IFNs and the hypothesis that the complications of dengue virus infection (haemorrhagic fever and shock) may be due to immunopathology.
INTRODUCTION
Interferons (IFNs) appear to have very important roles in the host response to virus infections because they have potent antiviral activities and modulate immune responses (Friedman & Vogel, 1983) . IFNs augment natural killer (NK) cell activity (Herberman et al., 1979) , increase the expression of major histocompatibility antigens (Kelley et al., 1984) , and increase the susceptibility of virus-infected cells to lysis by virus-specific cytotoxic T lymphocytes (Bukowski & Welsh, 1985) . We recently reported the production of high titres of IFN-ct by peripheral blood lymphocytes (PBL) of non-immune donors following exposure to dengue virus-infected cells in natural killing assays. The IFN-ct produced did not appear to explain the augmented killing of dengue virus-infected cells since neutralization with specific antisera did not block the increased killing of these cells (Kurane et al., 1984) . We had also reported that PBL stimulated with influenza virus-infected autologous cells produced high titres of IFN-7 as well as some IFN-ct, and we attributed the IFN-7 production to previous immunization with influenza viruses (Ennis & Meager, 1981) .
In the present report, we have analysed in more detail the interaction between the PBL of nonimmune donors and dengue virus-infected cells, which results in IFN production. Glutaraldehyde-fixed, dengue virus-infected cells also induce IFN from PBL. We have identified the IFN producer cell using monoclonal antibodies and employed a radioimmunoassay (RIA) with monoclonal antibodies specifically to detect human IFN-~ and IFN-~. Non-immune PBL exposed to dengue virus-infected cells produce both IFN-ct and IFN-7. This observation that 0000-6955 © 1986 SGM dengue virus-infected cells induce IFN-y in addition to IFN-ct from non-immune PBL is important, since IFN-), has immunoregulatory functions (Farrar et al., 1981) , and acts synergistically to potentiate the antiviral activity of IFN-ct (Oleszak & Stewart, 1984) .
METHODS

Human peripheral blood mononuclear cells (PBMC).
Peripheral blood specimens were obtained from healthy non-immune donors who did not have antibodies to dengue virus as determined by a plaque reduction neutralization test. All the donors were from dengue virus non-endemic areas. PBMC were separated by the Ficoll-Hypaque density gradient centrifugation method (Boyum, 1968) . Cells were resuspended at a concentration of 1 × l0 T to 3 x 107 per ml in RPMI 1640 medium (Flow Laboratories), containing 10~ foetal calf serum (FCS) and 10~o DMSO (Fisher Scientific, Fairlawn, N.J., U.S.A.) and were cryopreserved until use.
Viruses. Dengue virus type 1 Hawaian strain, type 2 New Guinea C strain, type 3 H87 (Phillipine) strain and type 4 H241 (Phillipine) strain were used for infection of Raji cells. These viruses were supplied by Dr W. E. Brandt, Walter Reed Army Institute of Research, U.S.A. These viruses were passed in mouse brain and then propagated in mosquito cells (C6/36) as previously described (Kurane et al., 1984) .
Cell cultures. Raji cells (Pulvertaft, 1964) and K562 cells (Lozzio & Lozzio, 1975) were cultured in RPMI/10~ FCS. Raji cells persistently infected with dengue virus type 2 were prepared as previously reported (Kurane et al., 1984) . Raji cells were also infected with dengue virus types 1, 3 and 4 in the presence of antisera to homologous viruses as enhancing antibodies, and we established Raji cells persistently infected with each type of dengue virus using limiting dilution techniques. Greater than 98~ of the dengue virus-infected Raji cells expressed virusspecific membrane and cytoplasmic antigens in indirect immunofluorescence assays using specific anti-dengue virus antisera. These dengue virus-infected cell lines were cultured in RPMI/20~ FCS, and these cells were more than 95~ viable as determined by dye exclusion testing with trypan blue. All cell cultures were free of mycoplasma. Mycoplasma infection was tested using 6-methylpurine deoxyriboside (Bethesda Research Laboratories) and Vero cells as indicator cells. The test is based on the observation that mycoplasma converts 6-methylpurine deoxyriboside into 6-methylpurine and 6-methylpurine riboside, both of which are toxic to mammalian cells (McGarrity & Carson, 1982) .
Titration oJdengue virus. The amount of infectious dengue virus produced by Raji cells infected with dengue viruses was determined by plaque titration on Veto cells. A 0.1 ml amount of the serially diluted culture supernatant fluid was placed on Vero cell monolayers in 24-well plates (Costar) and incubated at 37 °C for 2 h. The culture fluid was removed, the cells were washed once, and 1 ml 1 ~ agar (Difco) containing RPMI 1640, 10~ FCS, 0.5 ~ non-essential amino acids, 0.5 ~ essential vitamins and 0.3 ~o DEAE-dextran was used as an overlay. The plates were cultured at 37 °C for 7 days, stained with neutral red and the number of plaques was counted (Kurane et al., 1984) .
Monoclonal antibodies and other reagents. Anti-Leul I antibody reacts with human NK cells and neutrophils (Lanier et al., 1984 . OKM1 antibody reacts with monocytes, granulocytes and NK cells (Breard et al., 1980) . OKT3 antibody reacts with T lymphocytes (Kung et al., 1979) .
Anti-Leullb antibody was purchased from Becton Dickinson Co. OKM1 and OKT3 antibodies were purchased from Ortho Diagnostic Co. Cell separation by fluorescence activated cell sorter. Non-adherent PBL were stained by indirect membrane immunofluorescence, using various monoclonal antibodies and FITC-conjugated anti-mouse IgG (for OKM 1 and OKT3) or FITC-conjugated anti-mouse IgM (for anti-Leullb). Stained lymphocytes were sorted with a fluorescence activated cell sorter (FACS 440, Becton-Dickinson Co.) as previously reported (Kurane et al., 1984) . Cell viability after sorting exceeded 95~o by a trypan blue dye exclusion test. The purity of each of the sorted populations was greater than 96~o.
Treatment of PBL with monoclonal antibodies and complement. PBL (1 x l0 T) were suspended in 0-5 ml RPMI/I ~ FCS containing monoclonal antibody (1:10 dilution) and incubated at room temperature for 45 min. After being washed, the PBL were incubated with a l : 3 dilution of rabbit complement (Cedarlane Laboratories, Ontario, Canada) at 37 °C for 1 h. The cells were then suspended in phosphate-buffered saline (PBS) at room temperature for 15 min, washed twice, resuspended in RPMI/10~ FCS, and used as effector cells. After this treatment, less than 2~o of the residual cells reacted with the monoelonal antibody which had been added with complement.
Treatment of dengue virus-inJected cells with glutaraldehyde.
Dengue virus-infected and uninfected Raji cells were treated with glutaraldehyde as previously described (Neville, 1980) . Cells were washed three times with PBS, treated with 0.025~ glutaraldehyde in PBS for l0 min at room temperature, washed three times in PBS, resuspended in RPMI/10~o FCS, and used as inducer cells.
Pretreatment of cells with actinomycin D. Cells (4 x l0 ° per ml) were incubated with various concentrations of actinomycin D (Sigma) at 37 °C for 1 h, to inhibit the production of IFN (Levy et al., 1965) . Cells were washed three times and then were used as effector cells.
Induction oflFN. PBL (5 × 105) were cultured with 1 x 104 of inducer cells in 0-2 ml RPMI/10~ FCS at 37 °C for 16 h. After cultivation, 0.15 ml of the supernatants were harvested and examined for IFN activity. Dengue virus type 2-infected Raji cells were used as inducer cells unless otherwise stated.
IFN assays
Bioassay. IFN was assessed by a cytopathic effect reduction assay (Ennis & Meager, 1981) . Twofold serial dilutions of supernatant fluids obtained from PBL exposed to dengue virus-infected ceils were incubated on human fibroblast cells (trisomie for chromosome 21) for 20 h at 37 °C and then challenged with vesicular stomatitis virus. An international IFN standard was included in each assay, and the titres were read after 24 h at 37 °C.
Radioimmunoassay. The IFN content of supernatant fluids was also measured in RIA (Secher, 1981 ) specific for 1FN-~ and IFN-'/. Briefly, 6.5 mm diam. etched polystyrene beads coated with sheep polyclonal antiserum to IFN-ct or IFN-F were incubated with IFN-containing samples for 2 to 3 h at 4 °C, washed twice and then incubated with either radioiodinated '25I-MT4/E4 monoclonal antibody to IFN-e2 (Exley et al., 1984) or 125I-5J monoclonal antibody to IFN°), for 16 h at 4 °C. The beads were re-washed and counted in an LKB gamma counter. RIAs were calibrated in IU/ml using relevant international standards for HulFN-ct and HulFN-),. These monoclonal antibodies used to detect IFN-ct and IFN-~, are specific for IFN-ct and IFN-7, respectively, Levels of IFN as low as 10 U/ml were reproducibly measurable in these assays.
Neutralization oflFN. Neutralization of antiviral activity was performed using specific antisera to human ct, fl and V interferons. These anti-IFN antibodies were produced by one of us (A.M.); the sheep anti-IFN-ct had a titre of 1:10000, rabbit anti-IFN-fl had a titre of 1:2000 and rabbit anti-IFN-~, had a titre of 1:1000. Diluted IFN samples containing 10 U/ml were incubated for 2 h at room temperature with serial dilutions of antiserum and the residual IFN was titrated by the cytopathic effect reduction assay (Ennis & Meager, 1981) . In other experiments IFN samples containing 100 U/ml were incubated with 10-to 50-fold excess of antiserum of each type for 2 h at room temperature and the residual IFN activity was titrated,
RESULTS
Induction of lFN by dengue virus-infected cells
PBL of non-immune donors were cultured alone or with dengue virus type 2-infected or uninfected cells for 16 h, and the supernatant fluids were examined for IFN activity by bioassay (Table 1) . IFN activity was detected at titres from 150 to 1600 U/ml in the supernatant fluids of cultures containing both PBL and dengue virus-infected cells; however, very low titres of IFN were detected when PBL were cultured alone or with uninfected cells. IFN was not detectable in the culture supernatants of dengue virus type 2-infected cells alone or uninfected cells alone. We also examined IFN production using cells infected with dengue virus types 1, 3 and 4 as inducer In order to eliminate the possibility that the dengue virus-infected cells produced IFN after exposure to PBL, PBL and infected cells were pretreated with actinomycin D at doses of 0.64 and 2.56 I.tg/ml. Pretreatment with either dose of actinomycin D did not change the viability of the PBL, the dengue virus-infected or the uninfected cells. Pretreatment of PBL decreased the production of IFN from 800 U/ml to 25 U/ml; however, pretreatment of dengue virus-infected ceils did not change the titre of the produced IFN. These results indicate that PBL produce the IFN, not the dengue virus-infected cells.
Kinetics and effects of cell concentration on IFN production
The time course of IFN production was evaluated. IFN was detected as early as 2 h after the beginning of incubation. The titre reached a maximum at 16 h of incubation. The dose-response effect of various numbers of inducer cells was then evaluated. PBL (5 x 105) were cultured with 10 z to 106 dengue virus-infected cells for 16 h (Fig. 1) . There was an obvious dose-response relationship between the number of inducer cells (from 101 to 105) and the titre of IFN induced. 106 inducer cells were half as effective as 105 inducer cells, which may have been due to decreased contact between PBL and inducer cells at such a high concentration of cells.
Induction of lFN by glutaraldehyde-treated, dengue virus-infected cells
Dengue virus-infected Raji cells produced a low titre of infectious dengue virus (230 p.f.u./ml after 16 h of incubation of 5 x 10 ~ cells/ml). This observation raised the possibility that the IFN may have been produced by infection of PBL with dengue virus and not by the stimulation of PBL by dengue virus-infected cells, and so we performed additional studies.
We examined glutaraldehyde-treated, dengue virus-infected cells for their ability to induce IFN. Table 2 shows that the glutaraldehyde-treated cells also induced IFN from PBL. These glutaraldehyde-treated, dengue virus-infected cells did not produce infectious virus during 24 h of cultivation. In addition, a dengue virus-infected cell line, which produces no infectious virus, also induced a high titre of IFN (data not presented). These results indicate that production of IFN by PBL is due to stimulation of PBL by dengue virus-infected ceils and is not secondary to infectious dengue virus.
Characterization of lFN-producing PBL using monoclonal antibodies
PBL which produce IFN in response to dengue virus-infected cells were characterized using three monoclonal antibodies: OKM1, anti-Leull and OKT3 antibodies. The PBL were pretreated with monoclonal antibody and complement, and incubated with inducer cells for 16 h (Table 3) . IFN activity was assessed by bioassay. Pretreatment of PBL with OKM1 and • IFN was assessed by bioassay after 16 h of incubation. Ratio of PBL :inducer cell was 40:1.
complement, and anti-Leu 11 antibody and complement decreased the titre of the IFN produced in all experiments. Low but significant titres of IFN were, however, produced by PBL depleted of M 1 + cells or Leull + cells. Pretreatment of PBL with OKT3 and complement did not decrease the titre of produced IFN.
In the next series of experiments, PBL were sorted by FACS after reaction with OKM1, antiLeul 1 or OKT3 antibodies, and were then incubated with inducer cells (Table 4) . M1 + and T3-cells produced higher titres of IFN than did M1-and T3 + cells, respectively. Leul 1* cells and Leul l-cells produced almost the same titres of IFN. The results shown in Tables 3 and 4 are consistent and indicate that the predominant IFN-producing cells are contained in M1 + and T3-subsets, and that the Leul l+ subset contains some IFN-producing cells.
Characterization of produced IFN
The IFNs produced were characterized by RIA and bioassay. In the bioassay the produced IFN was characterized as IFN-c(, because it was neutralized by antiserum to IFN-ct but was not significantly neutralized by antisera to IFN-fl or IFN-~ (data not presented). In the RIA, however, some IFN-y as well as IFN-ct was detected in the supernatant fluids obtained from cultures which contained both PBL and dengue virus-infected cells. Although the titre of IFN-~ was not as high as that of IFN-ct, the presence of IFN-~ was consistent in all experiments (Table   5 ).
We then characterized the PBL which produced IFN-ct and IFN-~ using OKM1 and OKT3 antibodies, because these two antibodies most clearly discriminated IFN-producing PBL as shown in Tables 3 and 4 . Treatment of PBL with OKMI and complement decreased the production of both IFN-~ and IFN-7 as measured by RIA (Table 6 ). PBL pretreated with OKT3 and complement (T3-cells) produced a higher titre of IFN-ct and IFN-~ than did PBL pretreated with complement alone, probably because of the resulting enrichment of IFNproducing cells. The results indicate that both IFN-ct and IFN-y are predominantly produced by PBL contained in M1 + and T3-subsets. I. KURANE, A. MEAGER AND F. A. ENNIS :~ § Statistically significant: :1: P <0.02; § P <0.05. 
DISCUSSION
In this paper, we report that dengue virus-infected cells induced high levels of IFN from nonimmune human PBL. Characterization of the IFN-producing cells using monoclonal antibodies showed that the PBL predominantly responsible for producing IFN were contained in M 1 ÷ and T3-subsets. Both IFN-~ and IFN-7 were produced by M1 ÷ and T3-cells as determined by RIA employing specific monoclonal antibodies to detect IFN-c~ or -V.
Production of IFN by PBL of non-immune donors in response to various virus-infected cells has been reported (Santoli et al., 1978 ; Casali & Oldstone, 1982; Fitzgerald et al., 1982; Blazar et al., 1984) . Most investigate-s have characterized the produced IFN as IFN-~. We detected both IFN-~ and IFN-7 in the sup~rnatant fluids of cultures containing PBL and dengue virus-infected cells. The titre of IFN-y was not as high as that of IFN-~, but the presence of IFN-v was consistent in all experiments. The present results are interesting and suggest that cells infected with other viruses may induce IFN-v from the PBL of non-immune donors, which previously may not have been detected due to the inherent limitations of the bioassay and neutralization techniques. We had failed to detect IFN-v by standard neutralization tests because the dilution techniques used in the neutralization assay would not detect a lower titred IFN component.
Lymphocytes which produced IFN after addition of virus have been characterized as null cells (Peter et al., 1980) and as large granular lymphocytes (Djeu et al., 1982) . Our results are consistent with the previous reports which indicated that IFN-producing cells have characteristics of NK cells, because it has been reported that most human NK ceils have M1 antigen (Ortaldo et al., 1981) and that Leul 1 antigen is expressed on essentially all functional NK cells in peripheral blood (Lanier et al., 1984) . We also found that PBL contained in M 1 ÷ and T3-fractions are responsible for producing both IFN-~ and IFN-v. It has been reported that NK cells produce both IFN-~ and -V depending on the method of stimulation (Gronberg et al., 1983; Nocera et al., 1985) . Our results suggest that NK cells produce IFN-~ and -V after stimulation by dengue virus-infected cells.
The role of IFNs produced by PBL exposed to dengue virus-infected cells in dengue infections remains to be studied. It has been reported that mouse serum which contained type 1 IFN activity showed therapeutic effects against dengue virus infection in mice (Liu, 1978) . IFN-v has been reported to be more active as an immunoregulatory agent than IFN-~ and IFN-/~ (Friedman & Vogel, 1983) . IFN-v but not IFN-~ or IFN-/3 induced HLA-DR antigen on human monocytes, and IFN-~, was more active in inducing HLA-A and -B antigens than IFN-~ and IFN-/~ (Kelley et al., 1984) . In addition to immunoregulatory effects, IFN-y potentiates the antiviral effect of IFN-~ and IFN-/~ (Oleszak & Stewart, 1984) . Although the titre of IFN-v produced was not as high as that of IFN-~, it is possible that IFN-~, as well as IFN-~ may play a role in recovery from dengue virus infection or in the pathogenesis of dengue haemorrhagic fever and dengue shock syndrome.
The mechanism of IFN induction by dengue virus-infected cells remains to be elucidated. Glutaraldehyde-treated, dengue virus-infected cells which do not produce infectious dengue virus induced IFN. In addition, a dengue virus-infected cell line which does not produce detectable infectious dengue virus induced IFN. These results indicate that infectivity of the dengue virus is not essential for the induction of IFN, and it is probable that some component expressed on the infected cells is responsible. Dengue virus has three structural proteins: V 1, V2 and V3. V3 may be the only exposed protein antigen on the virion and is responsible for haemagglutination (Russell et al., 1980) . It has been reported that the-haemagglutininneuraminidase glycoprotein of Sendai virus can induce IFN from mouse spleen cells (Ito & Hosaka, 1983) . This suggests that dengue virus proteins expressed on infected cells may be responsible for the induction of IFN. It has also been reported that non-virion proteins are present on the surface of dengue virus-infected cells (Cardiff &Lund, 1976) . Recently, it has been reported that monoclonal antibody to the NS1 antigen produced by infection with another flavivirus (yellow fever virus, strain 17D) fixed complement and lysed infected cells (Schlesinger et al., 1985) . Therefore, it is possible that non-virion proteins may be responsible for inducing IFNs, but this requires further analysis. Thus, two interesting questions remain to be elucidated. (i) Are proteins expressed on dengue virus-infected cells responsible for the induction of IFN?
(ii) What role does the produced IFN play in the immune response to dengue virus ? Answers to these questions will lead us to a better understanding of immune responses and their possible role in dengue virus infections.
